Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
2023
Alzheimers Dement. 2023 Jul;19(7):2943-2955. doi: 10.1002/alz.12907.